Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Anixa Biosciences Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 58 | 1 | 66 | +9 |
| Shares | 5.61M | 14.0K | 5.35M | −242.9K (−4.3%) |
| Value | $16.0M | $37.6K | $17.6M | +$1.66M (+10.4%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Anixa Biosciences Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 70,938 | $234.1K | 0.00% |
| Bradley Foster & Sargent Inc | 20,263 | $66.9K | 0.00% |
| CIBC Private Wealth Group, LLC | 14,600 | $48.2K | 0.00% |
| Marshall Wace, LLP | 11,722 | $38.7K | 0.00% |
| NewEdge Wealth, LLC | 12,500 | $37.6K | 0.00% |
| Benjamin Edwards Inc | 11,200 | $37.0K | 0.00% |
| Millennium Management LLC | 10,582 | $34.9K | 0.00% |
| GWM Advisors LLC | 10,040 | $33.1K | 0.00% |
| NBT Bank N A | 2,000 | $6.60K | 0.00% |
| Livelsberger Financial Advisory | 1,634 | $5.39K | 0.10% |
| Raymond James Financial Inc | 1,260 | $4.16K | 0.00% |
| Parkside Financial Bank & Trust | 602 | $1.99K | 0.00% |
Sold out (3)
Institutions that held Anixa Biosciences Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Atria Wealth Solutions, Inc. | 24,000 | $68.6K |
| SG Americas Securities, LLC | 15,514 | $44.0K |
| Hurley Capital, LLC | 314 | $898 |
Not filed for Q2 2025 yet (1)
Institutions that held Anixa Biosciences Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Concorde Asset Management, LLC | 13,969 | $37.6K |